The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Thomas Pilgrim
Showing 1-20 of 26 articles
Continued non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists during transcatheter aortic valve implantation
Mangner N,
Brinkert M,
Keller L,
Moriyama N,
Hagemeyer D,
Haussig S,
Crusius L,
Kobza R,
Abdel-Wahab M,
Laine M,
Stortecky S,
Pilgrim T,
Nietlispach F,
Ruschitzka F,
Thiele H,
Toggweiler S,
Linke A
February 6, 2023 | 10.4244/EIJ-D-22-00521
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement
Okuno T,
Demirel C,
Tomii D,
Heg D,
Häner J,
Siontis G,
Lanz J,
Räber L,
Strotecky S,
Fürholz M,
Praz F,
Windecker S,
Pilgrim T
November 18, 2022 | 10.4244/EIJ-D-22-00342
Five-year outcomes of mild paravalvular regurgitation after transcatheter aortic valve implantation
Okuno T,
Tomii D,
Heg D,
Lanz J,
Praz F,
Stortecky S,
Reineke D,
Windecker S,
Pilgrim T
May 15, 2022 | 10.4244/EIJ-D-21-00784
Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition
Gragnano F,
Spirito A,
Corpataux N,
Vaisnora L,
Galea R,
Gargiulo G,
Siontis G,
Praz F,
Lanz J,
Billinger M,
Hunziker L,
Stortecky S,
Pilgrim T,
Bär S,
Ueki Y,
Capodanno D,
Urban P,
Pocock S,
Mehran R,
Heg D,
Windecker S,
Räber L,
Valgimigli M
December 3, 2021 | 10.4244/EIJ-D-21-00181
Outcomes of valve-in-valve transcatheter aortic valve implantation with and without bioprosthetic valve fracture
Brinkmann C,
Abdel-Wahab M,
Bedogni F,
Bhadra O,
Charbonnier G,
Conradi L,
Hildick-Smith D,
Kargoli F,
Latib A,
Van Mieghem N,
Mylotte D,
Landes U,
Pilgrim T,
Stripling J,
Taramasso M,
Tchétché D,
Testa L,
Thiele H,
Webb J,
Windecker S,
Witt J,
Wohlmuth P,
Schofer J
November 19, 2021 | 10.4244/EIJ-D-21-00254
Transcatheter paravalvular leak closure: catch me if you can
Pilgrim T,
Okuno T
October 20, 2021 | 10.4244/EIJV17I9A121
Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores
Ueki Y,
Bär S,
Losdat S,
Otsuka T,
Zanchin C,
Zanchin T,
Gragnano F,
Gargiulo G,
Siontis G,
Praz F,
Lanz J,
Hunziker L,
Stortecky S,
Pilgrim T,
Heg D,
Valgimigli M,
Windecker S,
Räber L
August 28, 2020 | 10.4244/EIJ-D-20-00052
Feasibility and safety of transcaval transcatheter aortic valve implantation: a multicentre European registry
Costa G,
de Backer O,
Pilgrim T,
Kasel AM,
Redwood S,
Aminian A,
Lanz J,
Michel J,
Patterson T,
Windecker S,
Prendergast B,
Greenbaum A,
Søndergaard L
February 7, 2020 | 10.4244/EIJ-D-19-00797
Optimal fluoroscopic viewing angles of right-sided heart structures in patients with tricuspid regurgitation based on multislice computed tomography
Xiong T,
Pighi M,
Thériault-Lauzier P,
Leipsic J,
Spaziano M,
Martucci G,
Buithieu J,
Mousavi N,
Pilgrim T,
Praz F,
Windecker S,
Chen M,
Piazza N
November 15, 2019 | 10.4244/EIJ-D-19-00618
Bioprosthetic Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA) during transcatheter aortic valve-in-valve implantation with bioprosthetic valve fracturing via the transcaval access
Lanz J,
Pilgrim T,
Greenbaum A,
Windecker S
October 19, 2018 | 10.4244/EIJ-D-18-00553
Current state of alternative access for transcatheter aortic valve implantation
Lanz J,
Greenbaum A,
Pilgrim T,
Tarantini G,
Windecker S
September 7, 2018 | 10.4244/EIJ-D-18-00552
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial
Iglesias JF,
Muller O,
Zaugg S,
Roffi M,
Kurz D,
Vuilliomenet A,
Weilenmann D,
Kaiser C,
Tapponnier M,
Heg D,
Valgimigli M,
Eeckhout E,
Jüni P,
Windecker S,
Pilgrim T
August 24, 2018 | 10.4244/EIJ-D-17-00734
Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation
Franzone A,
O’Sullivan C,
Stortecky S,
Heg D,
Lanz J,
Vollenbroich R,
Praz F,
Piccolo R,
Asami M,
Roost E,
Räber L,
Valgimigli M,
Windecker S,
Pilgrim T
April 7, 2017 | 10.4244/EIJ-D-16-00790
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction
Pilgrim T,
Piccolo R,
Heg D,
Roffi M,
Tüller D,
Vuilliomenet A,
Muller O,
Cook S,
Weilenmann D,
Kaiser C,
Jamshidi P,
Khattab A,
Taniwaki M,
Rigamonti F,
Nietlispach F,
Blochlinger S,
Wenaweser P,
Jüni P,
Windecker S
December 9, 2016 | 10.4244/EIJY15M12_09
External validity of a contemporaneous primary percutaneous coronary intervention trial in patients with acute ST-elevation myocardial infarction: insights from a single-centre investigation
Spitzer E,
Hadorn S,
Zanchin T,
Yamaji K,
Moschovitis A,
Pilgrim T,
Stortecky S,
Jüni P,
Heg D,
Windecker S,
Räber L
October 20, 2016 | 10.4244/EIJV12I9A185
Bilateral, reversible coronary obstruction during aortic valve-in-valve implantation of a repositionable valve system
Praz F,
Moschovitis A,
Stortecky S,
Pilgrim T,
Eberle B,
Windecker S
October 20, 2016 | 10.4244/EIJV12I9A194
Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial
Franzone A,
Taniwaki M,
Rigamonti F,
Heg D,
Piccolo R,
Roffi M,
Tüller D,
Muller O,
Vuilliomenet A,
Cook S,
Weilenmann D,
Kaiser C,
Jamshidi P,
Jüni P,
Windecker S,
Pilgrim T
August 5, 2016 | 10.4244/EIJV12I5A99
Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study
Räber L,
Onuma Y,
Brugaletta S,
Garcia-Garcia H,
Backx B,
Iñiguez A,
Jensen L,
Cequier-Fillat A,
Pilgrim T,
Christiansen E,
Hofma S,
Suttorp M,
Serruys P,
Sabaté M,
Windecker S
July 20, 2016 | 10.4244/EIJY15M08_03
Effect of resting heart rate on two-year clinical outcomes of high-risk patients with severe symptomatic aortic stenosis undergoing transcatheter aortic valve implantation
O’Sullivan C,
Spitzer E,
Heg D,
Praz F,
Stortecky S,
Huber C,
Carrel T,
Pilgrim T,
Windecker S
July 20, 2016 | 10.4244/EIJV12I4A83
Will this trial change my practice? ABSORB II trial (a bioresorbable vascular scaffold versus drug-eluting stent in coronary disease)
De Palma R,
Byrne R,
van Geuns R,
Pilgrim T,
Jüni P,
Al Rashdan I
July 20, 2015 | 10.4244/EIJV11I3A72
1
2
Latest news
AHEAD OF PRINT
Oesophageal and gastric injuries in tricuspid TEER
FREE ARTICLE - Tanja Kuecken et al
March 29, 2023
AHEAD OF PRINT
Heavily calcified CTOs: an expert review from the European CTO Club
FREE ARTICLE - Kambis Mashayekhi et al
March 27, 2023
NEW ISSUE
ESC/EAPCI Consensus Statement on Renal Denervation; the Future of TMVR; Mini-focus on Interventional Pharmacology...
March 20, 2023
AHEAD OF PRINT
Diagnostic accuracy of OFR
FREE ARTICLE - Fukang Hu et al
March 23, 2023
AHEAD OF PRINT
Contemporary transcatheter prostheses in small annuli
FREE ARTICLE - Pier Pasquale Leone et al
March 21, 2023
AHEAD OF PRINT
Early changes in cardiac damage after TAVI
FREE ARTICLE - Yaoyao Zhou et al
March 17, 2023
AHEAD OF PRINT
Posterior pericardiotomy for the prevention of atrial fibrillation
FREE ARTICLE - Ahmed AbdelAziz et al
March 16, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke